Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes Trial

    NEXT STORY
    Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
    PREV STORY
    Chembio Diagnostics to Participate in Upcoming Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    IMV Inc. Announces Early Positive Results from Phase 2 Clinical Trial of Lead Candidate DPX-Survivac in Combination with Merck’s Keytruda® in Patients with DLBCL

    Tumor Regressions Observed in Two of First Four Evaluable Patients, Including One Partial Response ...

    author_avatar
    NASDAQ Market News

    Merus Announces Pricing of Public Offering of Common Shares

    author_avatar
    NASDAQ Market News

    Global Home Infusion Therapy Market Will Reach USD 27.95 Billion by 2022: Zion Market Research

    Sarasota, FL, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

    author_avatar
    NASDAQ Market News